About infectious disease testing
Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.

Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.

Technavio’s analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.

[Covered in this report]
The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases:

The market is segmented based on technology:
• Molecular diagnostic test
• POCT
• Immunodiagnostic test

The POCT for infectious disease is further segmented based on application:
• HIV
• Respiratory
• HAIs
• Sexual health
• Tropical diseases
• Hepatitis

In addition, the market is segmented based on products:
• Equipment
• Consumables

Technavio’s report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

[Key vendors]
• Abbott Diagnostics
• Alere
• Beckman Coulter Diagnostics
• Roche
• Siemens Healthcare

[Other prominent vendors]
• Abaxis
• Acon Laboratories
• Avioq
• BD
• Bio-Rad Laboratories
• Cavidi
• Cepheid
• Chembio Diagnostic Systems
• Clarity Diagnostics
• EMD Millipore
• Epitope Diagnostic
• Gold Standard Diagnostics
• Hologic
• Immunetics
• InBios International
• Life Technologies
• Maxim Biomedical
• Mindray
• OraSure Technologies
• Ortho Clinical Diagnostics
• Quidel Corporation
• Thermo Fisher Scientific
• Trinity Biotech

[Market driver]
• North America free trade agreement
• For a full, detailed list, view our report

[Market challenge]
• Medical device excise tax law
• For a full, detailed list, view our report

[Market trend]
• Development of innovative diagnostics initiatives
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?